tiprankstipranks
Trending News
More News >
NanoViricides Inc (NNVC)
:NNVC
Advertisement

NanoViricides (NNVC) Price & Analysis

Compare
558 Followers

NNVC Stock Chart & Stats


NanoViricides News

NNVC FAQ

What was NanoViricides Inc’s price range in the past 12 months?
NanoViricides Inc lowest stock price was $0.94 and its highest was $1.92 in the past 12 months.
    What is NanoViricides Inc’s market cap?
    NanoViricides Inc’s market cap is $22.10M.
      When is NanoViricides Inc’s upcoming earnings report date?
      NanoViricides Inc’s upcoming earnings report date is Nov 24, 2025 which is in 79 days.
        How were NanoViricides Inc’s earnings last quarter?
        Currently, no data Available
        Is NanoViricides Inc overvalued?
        According to Wall Street analysts NanoViricides Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does NanoViricides Inc pay dividends?
          NanoViricides Inc does not currently pay dividends.
          What is NanoViricides Inc’s EPS estimate?
          NanoViricides Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NanoViricides Inc have?
          NanoViricides Inc has 16,072,000 shares outstanding.
            What happened to NanoViricides Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of NanoViricides Inc?
            Currently, no hedge funds are holding shares in NNVC

            Company Description

            NanoViricides Inc

            NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

            NanoViricides (NNVC) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Enlivex
            Tenax Therapeutics
            Pulmatrix
            Ovid Therapeutics
            CalciMedica

            Ownership Overview

            6.55%4.24%0.89%85.37%
            6.55%
            Insiders
            0.89% Other Institutional Investors
            85.37% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis